|
Sol gel Technologies Ltd (NASDAQ: SLGL) |
|
Sol gel Technologies Ltd
SLGL's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Sol Gel Technologies Ltd growth rates, revenue grew
by 642.47 % in the fourth quarter of 2024 from the same quarter a year ago.
Ranking at No. 3519
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Sol Gel Technologies Ltd net loss decreased from $-27 millions, to $-11 millions in fourth quarter of 2024,
• More on SLGL's Growth
|
|
Sol Gel Technologies Ltd realized a net loss in trailing twelve months.
Sol Gel Technologies Ltd realized cash reduction of $ 0 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 18.83.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.
• More on SLGL's Valuation
|
|
|
|
|
Sol Gel Technologies Ltd realized net loss in trailing twelve months.
Sol Gel Technologies Ltd realized cash outflow of $ 0per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 18.83.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.
Sol Gel Technologies Ltd Price to Book Ratio is at 7.53 lower than Industry Avg. of 33.1. and higher than S&P 500 Avg. of 0.01
• More on SLGL's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com